背上痤疮怎样治疗

背上痤疮如何治疗配图，仅供参考

4.2.2. Treatment
First-line treatments for acne include topical applications of retinoids,benzoyl peroxide,azelaic acid,and/or combinations of these. The US Food and Drug Administration has granted approval for the utilization of 4 topical retinoids in acne therapy. These retinoids include tretinoin,adapalene,tazarotene,and trifarotene. Oral isotretinoin is the only therapeutic approach that directly or indirectly addresses all currently recognized pathogenic factors associated with acne. Tetracyclines are widely utilized oral antibiotics that effectively decrease Cutibacterium acnes and exhibit anti-inflammatory properties. The use of oral antibiotics is a frequently employed approach to achieve relatively rapid control of moderate to severe inflammatory acne. Typically,oral antibiotics are utilized in conjunction with a topical retinoid and benzoyl peroxide. However,antibiotic-induced antimicrobial resistance is becoming increasingly significant on a worldwide scale. The present recommendations in all acne guidelines strive to minimize the utilization of antibiotics for acne treatment. Consequently,there is growing interest in the utilization of antimicrobial peptides and agents that regulate populations of Cutibacterium acnes,including probiotic preparations and gels that degrade biofilm matrices. In addition to mild comedolytic and anti-inflammatory properties,benzoyl peroxide restricts the development of bacterial resistance to topical and oral antibiotics,and has higher efficacy than topical antibiotics alone.
?nc? I et al conducted an assessment of somatosensory amplification,anxiety,and depression levels among acne patients. The researchers determined that there exists a noteworthy association between somatosensory amplification,depression,and health anxiety among individuals with acne. They argue that an interdisciplinary strategy that integrates both psychiatry and dermatology would be advantageous for the treatment of acne and the overall management of patients.","department":"